Medicare Enrolled
Dr. Alexander Dehaan, D.O.
Urology Physician · Wyoming, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dehaan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dehaan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dehaan
Dr. Alexander Dehaan is an urology physician in Wyoming, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dehaan performed 668 Medicare services across 540 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dehaan received a total of $8,652 from 58 pharmaceutical and/or device companies across 398 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dehaan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 50% volume in MI
$8,652 industry payments
Medicare Practice Summary
Medicare Utilization ↗668
Medicare services
Top 50% in MI for urology physician
540
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~35 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
160 | $52 | $138 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
84 | $86 | $204 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
70 | $11 | $44 |
| Injection, garamycin, gentamicin, up to 80 mg | 52 | $2 | $4 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
46 | $162 | $442 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $103 | $312 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
44 | $3 | $10 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
32 | $131 | $283 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
31 | $26 | $70 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
29 | $103 | $296 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
27 | $183 | $484 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
27 | $64 | $193 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $31 | $87 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,652
Total received (2018-2024)
Avg $1,236/year across 7 years
Top 22% in MI for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
398
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,340 (96.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$312 (3.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,266
2023
$1,335
2022
$1,255
2021
$1,418
2020
$805
2019
$1,324
2018
$1,248
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$216
Ferring Pharmaceuticals Inc.
$105
Laborie Medical Technologies Corp.
$104
Janssen Scientific Affairs, LLC
$88
PFIZER INC.
$70
Myriad Genetic Laboratories, Inc.
$63
ABBVIE INC.
$59
UROGEN PHARMA, INC.
$57
AstraZeneca Pharmaceuticals LP
$52
Novartis Pharmaceuticals Corporation
$51
Astellas Pharma US Inc
$51
Olympus America Inc.
$47
Merck Sharp & Dohme LLC
$47
Janssen Biotech, Inc.
$46
Ambu Inc.
$30
Telix Pharmaceuticals
$24
Sumitomo Pharma America, Inc.
$23
ACCORD HEALTHCARE, INC.
$22
Dendreon Pharmaceuticals LLC
$22
PROGENICS PHARMACEUTICALS, INC.
$21
Axonics, Inc.
$20
Blue Earth Diagnostics Limited
$17
Verity Pharmaceuticals Inc.
$17
ARRAY BIOPHARMA INC
$14
Top 3 companies account for 33.6% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,186
PFIZER INC.
$604
Janssen Biotech, Inc.
$526
Myriad Genetic Laboratories, Inc.
$503
NeoTract Inc.
$412
Boston Scientific Corporation
$405
Axonics, Inc.
$365
Coloplast Corp
$309
AstraZeneca Pharmaceuticals LP
$259
Bayer HealthCare Pharmaceuticals Inc.
$239
PROCEPT BioRobotics Corporation
$235
Myovant Sciences Inc.
$232
Teleflex LLC
$218
Medtronic USA, Inc.
$194
COLOPLAST CORP
$192
Olympus America Inc.
$189
Blue Earth Diagnostics Limited
$162
Amgen Inc.
$158
Dendreon Pharmaceuticals LLC
$156
Laborie Medical Technologies Corp.
$145
Ferring Pharmaceuticals Inc.
$145
ABBVIE INC.
$134
Merck Sharp & Dohme LLC
$115
Janssen Scientific Affairs, LLC
$110
AbbVie, Inc.
$110
AbbVie Inc.
$104
UROGEN PHARMA, INC.
$96
UroGen Pharma, Inc.
$90
Janssen Products, LP
$85
Allergan Inc.
$82
BOSTON SCIENTIFIC CORPORATION
$69
Sun Pharmaceutical Industries Inc.
$58
E.R. Squibb & Sons, L.L.C.
$57
Endo Pharmaceuticals Inc.
$56
Sumitomo Pharma America, Inc.
$56
Novartis Pharmaceuticals Corporation
$51
Progenics Pharmaceuticals, Inc.
$51
Merck Sharp & Dohme Corporation
$47
TOLMAR Pharmaceuticals, Inc.
$44
ACCORD HEALTHCARE, INC.
$40
Verity Pharmaceuticals Inc.
$36
Ambu Inc.
$30
Rochester Medical Corporation
$26
Telix Pharmaceuticals
$24
Alexion Pharmaceuticals, Inc.
$22
PROGENICS PHARMACEUTICALS, INC.
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
Accord Healthcare, Inc.
$20
Synergy Pharmaceuticals Inc
$19
Tolmar, Inc.
$19
GENZYME CORPORATION
$18
Janssen Pharmaceuticals, Inc
$17
AKRIMAX PHARMACEUTICALS, LLC
$16
Supernus Pharmaceuticals, Inc.
$15
DAVOL INC.
$15
Antares Pharma, Inc.
$14
ARRAY BIOPHARMA INC
$14
Foundation Medicine, Inc.
$11
Top 3 companies account for 26.8% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ADVANCE · AMS · AMS 700 CXR RTE Kit · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · ARISTA AH · AVEED · Androgel · Axonics r-SNM System · Axumin · BOTOX · BRAC CDx · BRACAnalysis CDx · BRIDION · Bulkamid · CAMCEVI · Capio RP · ELIGARD · ERLEADA · EVENITY · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL - BPH · General - Erectile Dysfunction · ILLUCCIX · INTERSTIM · Isiris · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Nubeqa · ONGLYZA · OPDIVO · ORGOVYX · Olympus Cystoscopes · Olympus Ureteroscopes · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · POSLUMA · PREMARIN · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · REZUM · SOLIRIS · SPEEDICATH · SWISS LITHOCLAST TRILOGY · Solyx SIS System · SpaceOAR VUE System - 10mL · SpeediCath · Stendra · THROMBIN · THROMBIN-JMI · TITAN · TOROSA · Titan · Trelstar · Trulance · UROLIFT · UroLift · UroLift System · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
48
Per 100K population
7.3
County median income
$80,390
Nearest hospital
UNIVERSITY OF MICHIGAN HEALTH - WEST
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dehaan is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dehaan experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Dehaan performed 160 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dehaan receive payments from pharmaceutical companies?
Yes. Dr. Dehaan received a total of $8,652 from 58 companies across 398 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dehaan's costs compare to other urology physicians in Wyoming?
Dr. Dehaan's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dehaan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Wyoming
Browse urology physicians in Wyoming ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MI
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MI
Which MI urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology